Skip to main content

Find Clinical Trials

Home
Conditions
B-cell Acute Lymphoblastic Leukemia

Clinical trial condition

B-cell Acute Lymphoblastic Leukemia

Explore clinical trials studying B-cell Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

62 public trials 39 recruiting studies

Refine in advanced search Browse all conditions

B-cell Acute Lymphoblastic Leukemia trial results

Active, Not Recruiting

Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies

NCT06220097

Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Refractory, Burkitt Lymphoma, +16 more
Locations: Union Hospital, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Active, Not Recruiting

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL

NCT03962465

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

University of Virginia Charlottesville, Virginia, United States

VCU Massey Cancer Center Richmond, Virginia, United States

University of Wisconsin Madison, Wisconsin, United States

View Trial Details